COVID-19 Trials in Plymouth, United Kingdom
Conditions / COVID-19 / Plymouth, United Kingdom
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05815498 | A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 | COMPLETED | — |
| NCT05822583 | Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial | COMPLETED | PHASE4 |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) | COMPLETED | PHASE3 |
| NCT04351802 | CORonavirus (COVID-19) Diagnostic Lung UltraSound Study | COMPLETED | — |
| NCT05305651 | Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19 | COMPLETED | PHASE4 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | COMPLETED | PHASE3 |
| NCT05629962 | SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 | COMPLETED | PHASE3 |
| NCT05092529 | Psychological Impact of COVID-19 on Intensive Care Survivors | COMPLETED | — |
| NCT04732949 | Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 | COMPLETED | PHASE3 |
| NCT04973449 | Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults | COMPLETED | PHASE2/PHASE3 |